{
  "id": "5c65484ee842deac6700001f",
  "type": "yesno",
  "question": "Can mogamulizumab be used for the treatment of cutaneous T-cell lymphoma?",
  "ideal_answer": "Yes, mogamulizumab can be used for the treatment of cutaneous T-cell lymphoma.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29298770"
  ],
  "snippets": [
    {
      "text": "In the large international phase III MAVORIC trial, patients with previously treated cutaneous T-cell lymphoma who received the anti-CCR4 monoclonal antibody mogamulizumab experienced significantly longer progression-free survival and higher response rates, as well as better quality of life, than those who received vorinostat, a standard therapy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29298770",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}